This article has been updated from a previous version to include information on the company's stock price.

NEW YORK (GenomeWeb News) - Agilent Technologies yesterday reported that revenues for its Bio-analytical segment declined 8 percent in its third fiscal quarter as total revenues fell 27 percent.

For the three months ended July 31, Agilent posted total revenues of $1.06 billion, a 27 percent falloff from $1.4 billion in the year-ago period but an improvement over analyst estimates of $1.02 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.